Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1995;95(1):111–132. doi: 10.1007/BF01435005

Five myths about AIDS that have misdirected research and treatment

Robert S Root-Bernstein 1
PMCID: PMC7087958  PMID: 7744256

Abstract

A number of widely repeated and factually incorrect myths have pervaded the AIDS research literature, misdirecting research and treatment. Five of the most outstanding are: 1) that all risk groups develop AIDS at the same rate following HIV infection; 2) that there are no true seroreversions following HIV infection; 3) that antibody is protective against HIV infection; 4) that the only way to treat AIDS effectively is through retroviral therapies; and 5) that since HIV is so highly correlated with AIDS incidence, it must be the sole necessary and sufficient cause of AIDS. A huge body of research, reviewed in this paper, demonstrates the falsity of these myths. 1) The average number of years between HIV infection and AIDS is greater than 20 years for mild hemophiliacs, 14 years for transfussion severe hemophiliacs, 10 years for old severe hemophiliacs, 10 years for homosexual men, 6 years for transfusion patients of all ages, 2 years for transplant patients, and 6 months for perinatally infected infants. These differences can only be explained in terms of risk-group associated cofactors. 2) Seroreversions are common. Between 10 and 20 percent of HIV-seronegative people in high risk groups have T-cell immunity to HIV, and may have had one or more verified positive HIV antibody tests in the past. 3) Antibody, far from being protective against HIV, appears to be highly diagnostic of loss of immune regulation of HIV, and some evidence of antibody-enhancement of infection exists. 4) Non-retroviral treatments of HIV infection, including safer sex practices, elimination of drug use, high nutrient diets, and limited reexposure to HIV and its cofactors have proven to be effective means of preventing or delaying onset of AIDS. 5) Many immunosuppressive factors, including drug use, multiple concurrent infections, and exposure to alloantigens, are as highly correlated with AIDS risk groups as HIV. These data are more consistent with AIDS being a multifactorial or synergistic disease than a monofactorial one.

Key words: AIDS progression, HIV seroreversion, HIV vaccination, behavioural risks, etiology

References

  1. Adams L.E., Donovan-Brand R., Friedman-Kien A., Ramahi K., Hess E.V. Sperm and seminal plasma antibodies in acquired immune deficiency (AIDS) and other associated syndromes. Clin. Immuno. Immunopathol. 1988;46:442–449. doi: 10.1016/0090-1229(88)90063-3. [DOI] [PubMed] [Google Scholar]
  2. Anderson R. AIDS: trends, predictions, controversy. Nature. 1993;363:393–394. doi: 10.1038/363393a0. [DOI] [PubMed] [Google Scholar]
  3. Andes W.A., Rangan S.R., Wulff K.M. Exposure of heterosexuals to human immunodeficiency virus and viremia: evidence for continuing risks in spouses of hemophiliacs. Sex Transm. Dis. 1989;16:68–73. doi: 10.1097/00007435-198904000-00005. [DOI] [PubMed] [Google Scholar]
  4. Anonymous, 1994. Fighting HIV: A clue from hemophilia. Science 263: 27. [PubMed]
  5. Aris A., Pomar J.L., Saura E. Cardiopulmonary bypass in HIV-positive patients. Ann. Thorac. Surg. 1993;55:1104–1107. doi: 10.1016/0003-4975(93)90015-a. [DOI] [PubMed] [Google Scholar]
  6. Aronson D.L. Cause of death in hemophilia patients in the United States from 1968–1979. Am. J. Haematol. 1988;27:7–12. doi: 10.1002/ajh.2830270103. [DOI] [PubMed] [Google Scholar]
  7. Atkinson K., Dodds A.J., Concannon A.J., Biggs J.C. The development of the acquired immunodeficiency syndrome after bone marrow transplantation. Med. J. Aust. 1987;147:510–512. [PubMed] [Google Scholar]
  8. Barnes D.M. Obstacles to an AIDS vaccine. Science. 1988;240:719–721. doi: 10.1126/science.2834823. [DOI] [PubMed] [Google Scholar]
  9. Biggar R.J., Anderson H.K., Ebbesen P., Mebye M., Goedert J.J. Seminal fluid excretion of cytomegalovirus related to immunosuppression in homosexual men. Br. Med. J. 1983;286:2010–2012. doi: 10.1136/bmj.286.6383.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bjork R.L., Jr. HIV-1: seven facets of functional molecular mimicry. Immunology Lett. 1991;28:91–95. doi: 10.1016/0165-2478(91)90104-i. [DOI] [PubMed] [Google Scholar]
  11. Blanch S., Tardieu M., Duliege A., Rouzioux C., le Deist F., et al. Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms. Am. J. Dis. Child. 1990;144:1210–1215. doi: 10.1001/archpedi.1990.02150350042021. [DOI] [PubMed] [Google Scholar]
  12. Brown P. AIDS researchers focus on immune response. New Scientist. 1992;8 August:16. [Google Scholar]
  13. Buimovici-Klein E., Lange M., Ong K.R., Grieco M.H., Cooper L.Z. Virus isolation and immune studies in a cohort of homosexual men. J. Med. Virol. 1988;25:371–385. doi: 10.1002/jmv.1890250402. [DOI] [PubMed] [Google Scholar]
  14. Burke D.S. Human HIV vaccine trials: Does antibodydependent enchancement pose a genuine risk? Perspectives Biol. Med. 1992;35:511–531. doi: 10.1353/pbm.1992.0048. [DOI] [PubMed] [Google Scholar]
  15. Burger H., Weiser B. Transient antibody to human immunodeficiency virus. Ann. Intern. Med. 1986;105:464–465. doi: 10.7326/0003-4819-105-3-464_2. [DOI] [PubMed] [Google Scholar]
  16. Burger H., Weiser B., Robinson W.S., Lifson J., Engleman E., et al. Transient antibody to lymphadenopathy-associated virus/human T-lymphotopic virus type III and T-lymphocyte abnormalities in the wife of a man who developed the aquired immonodeficiency syndrome. Ann. Int. Med. 1985;103:545–547. doi: 10.7326/0003-4819-103-4-545. [DOI] [PubMed] [Google Scholar]
  17. Callen M. Surviving AIDS. New York: Harper Collins; 1990. [Google Scholar]
  18. Centers for Disease Control, 1993. HIV/AIDS Surveillance Report, June 1993.
  19. Clerici M., Giorgi J.V., Chou C.C., Gudeman V.K., Zack J.A., Gupta P., Ho H.N., Nishanian P.G., Berzofsky J.A., Shearer G.M. Cell-mediated immune response to human immunodeficiency virus (HIV) type in seronegative homosexual men with recent sexual exposure to HIV-1. J. Infect. Dis. 1992;165:1012–1019. doi: 10.1093/infdis/165.6.1012. [DOI] [PubMed] [Google Scholar]
  20. Clerici M., Shearer G.M. A TH1 → TH2 switch is a critical step in the etiology of HIV infection. Immunology Today. 1993;14:107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  21. Cohen J. AIDS research: the mood is uncertain. Science. 1993;260:1254–1255. doi: 10.1126/science.8493564. [DOI] [PubMed] [Google Scholar]
  22. Cooper M.H., Maraninchi D., Gastaut J.A., Mannoni P., Carcassonne Y. HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population. J. Acquir. Immune. Defici. Syndr. 1993;6:277–284. [PubMed] [Google Scholar]
  23. Cuthbert R.J.G., Ludlum C.A., Tucker J., et al. Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort. Br. Med. J. 1990;301:956–961. doi: 10.1136/bmj.301.6758.956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Dalgleish A.G., Wilson S., Gompels M., Ludlam C., Gazzard B., Coates A.M., Habeshaw J. T-cell receptor variable gene products and early HIV-1 infection. Lancet. 1992;339:824–828. doi: 10.1016/0140-6736(92)90277-a. [DOI] [PubMed] [Google Scholar]
  25. Daniel V., Weimer R., Schimpf K., Opelz G. Autoantibodies against CD4- and CD8-positive T lymphocytes in HIV-infected hemophilia patients. Vox Sang. 1989;57:172–176. doi: 10.1111/j.1423-0410.1989.tb00817.x. [DOI] [PubMed] [Google Scholar]
  26. Daniel V., Weimer R., Zimmerman R., Huth-Kuhne A., et al. Improving CD4+lymphocyte counts in HIV-infected hemophilia patients: a favourable prognostic indicator? Immuno. Lett. 1991;30:27–30. doi: 10.1016/0165-2478(91)90085-o. [DOI] [PubMed] [Google Scholar]
  27. Darby S.C., Doll R., Thakrar B., Rizza C.R., Cox D.R. Time from infection with HIV to onset of AIDS in patients with haemophilia in the UK. Stat. Med. 1990;9:681–689. doi: 10.1002/sim.4780090615. [DOI] [PubMed] [Google Scholar]
  28. De Biasi R., Rocino A., Miraglia E., Mstrulle L., Quirino A.A. The impact of very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized prospective, two-year comparison with an intermediate purity concentrate. Blood. 1991;78:1919–1922. [PubMed] [Google Scholar]
  29. Donohoe R.M., Falek A.A. Neuroimmunomodulation by opiates and other drugs of abuse: relationship to HIV infection and AIDS. In: Bridge T.P., editor. Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. New York: Raven Press; 1988. pp. 165–172. [PubMed] [Google Scholar]
  30. Downs A.M., Ancelle-Park R.A., Costagliola D., Rigaut J.P., Brunet J.B. Transfusion-associated AIDS cases in Europe: Estimation of the incubation period, distribution and prediction of future cases. J. Acquir. Immune. Defic. Syndr. 1991;4:805–813. [PubMed] [Google Scholar]
  31. Dudding B.A., Wagner S.C., Zeller J.A., Gmelich J.T., French G.R., Top F.H., Jr. Fatal pneumonia associated with adenovirus type 7 in three military trainees. New Engl. J. Med. 1972;286:1289–1292. doi: 10.1056/NEJM197206152862403. [DOI] [PubMed] [Google Scholar]
  32. Duesberg P.H. Retroviruses as carcinogens and pathogens. Expectations and reality. Cancer Res. 1987;47:1199–1226. [PubMed] [Google Scholar]
  33. Duesberg P.H. Human immunodeficiency virus and acquired immunodeficiency syndrome: Correlation but not causation. Proc. Natl. Acad. Sci. U.S.A. 1989;86:755–764. doi: 10.1073/pnas.86.3.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Duesberg P.H. AIDS: non-infectious deficiencies acquired by drug consumption and other risk factors. Res. Immunol. 1990;141:5–17. doi: 10.1016/0923-2494(90)90097-i. [DOI] [PubMed] [Google Scholar]
  35. Duesberg P.H. The role of drugs in the origin of AIDS. Biomed. & Pharmacother. 1992;46:3–15. doi: 10.1016/0753-3322(92)90063-d. [DOI] [PubMed] [Google Scholar]
  36. Drew W.L., Mills J., Levy J., et al. Cytomegalovirus infection and abnormal T-lymphocyte subset ratios in homosexual men. Ann. Intern. Med. 1985;103:61–63. doi: 10.7326/0003-4819-103-1-61. [DOI] [PubMed] [Google Scholar]
  37. European Study Group on AIDS Risk factors for male to female transmission of HIV. Br. Med. J. 1989;298:411–415. doi: 10.1136/bmj.298.6671.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Eyster M.E., Gail M.H., Ballard J.O., Al-Mondhiry H., Goedert J.J. Natural history of human immunodeficiency virus infections in hemophiliacs: effects on T-cell subsets, platelet counts and age. Ann. Intern. Med. 1987;107:1–6. doi: 10.7326/0003-4819-107-1-1. [DOI] [PubMed] [Google Scholar]
  39. Farrugia A. Purity of factor concentrates and immune function in hemophiliacs. Blood. 1992;78:1919–1922. [PubMed] [Google Scholar]
  40. Fauci A.S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993;262:1011–1018. doi: 10.1126/science.8235617. [DOI] [PubMed] [Google Scholar]
  41. Farzadegan H., Polis M.A., Wolinsky S.M., Rinaldo C.R., Jr., Sninsky J.J., Kwok S., Griffiths R.L., Kaslow R.A., Phair J.P., Polk B.F., Saah A.A. Loss of human immunodeficiency virus type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann. Med. 1988;108:785–790. doi: 10.7326/0003-4819-108-6-785. [DOI] [PubMed] [Google Scholar]
  42. Fernandez-Cruz E., Fernandez A.M., Gutierrez C., et al. Progressive cellular immune impairment leading to development of AIDS: Two year prospective study of HIV infection in drug addicts. Clin. Exp. Immunol. 1988;72:190–195. [PMC free article] [PubMed] [Google Scholar]
  43. Fiala M., Cone L.A., Chang C.-M., Mocarski E.S. Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Res. 1986;2:175–181. doi: 10.1089/aid.1.1986.2.175. [DOI] [PubMed] [Google Scholar]
  44. Fribourg-Blanc A. Deux observations d'annulation spontanee d'une sero-positivite HIV. Med. Mal. Infect. 1988;4:216–218. [Google Scholar]
  45. Fumento M. The Myth of Heterosexual AIDS. New York: Harpers; 1990. [Google Scholar]
  46. Garry R.F., Kort J.J., Koch-Nolte F., Koch G. Tat contams a sequence related to snake neurotoxins. AIDS. 1991;5:1381–1384. doi: 10.1097/00002030-199111000-00017. [DOI] [PubMed] [Google Scholar]
  47. Gibbons J., Cory J.M., Hewlett I.K., Epstein J.S., Eyster M.E. Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood. 1990;76:1924–1926. [PubMed] [Google Scholar]
  48. Giesecke J., Scalia-Tomba G.P., Berglund O., Berntorp E., Schulman S., Stigendal L. Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. Br. Med. J. 1988;297:99–102. doi: 10.1136/bmj.297.6641.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Goedert J.J., Kessler C.M., Aledort L.M., et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. New Engl. J. Med. 1989;321:1141–1148. doi: 10.1056/NEJM198910263211701. [DOI] [PubMed] [Google Scholar]
  50. Golding H., Robey F.A., Gates F.T., III, Linder W., et al. Indentification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. J. Exp. Med. 1988;167:914–923. doi: 10.1084/jem.167.3.914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Goldsmith J.M., Deutsche J., Tang M., Green D. CD4 cells in HIV-1 infected hemophiliacs: effect of Factor VIII concentrates. Thromb. Haemost. 1991;66:415–419. [PubMed] [Google Scholar]
  52. Gottlieb M.S., Zackin R.A., Fiala M., Henry D.H., Marcel A.J., Combs K.L., Vieira J., et al. Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex. Ann. Intern. Med. 1991;115:84–91. doi: 10.7326/0003-4819-115-2-84. [DOI] [PubMed] [Google Scholar]
  53. Gomperts E.D., De Biasi R., De Vreker R. The impact of clotting factor concentrates on the immune system in individuals with hemophilia. Transfus. Med. Rev. 1992;6:44–54. doi: 10.1016/s0887-7963(92)70155-2. [DOI] [PubMed] [Google Scholar]
  54. Gougeon M.-L., Montagnier L. Apoptosis and AIDS. Science. 1993;260:1296–1271. doi: 10.1126/science.8098552. [DOI] [PubMed] [Google Scholar]
  55. Groenbladh L., Gunne L. Methadone-assisted rehabilitation of Swedish heroin addicts. Drug Alcohol Depend. 1989;24:31–37. doi: 10.1016/0376-8716(89)90005-7. [DOI] [PubMed] [Google Scholar]
  56. Gürtler L., Eberle J., Deinhardt F. Seroreversion in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 1989;110:946–948. doi: 10.7326/0003-4819-110-11-946. [DOI] [PubMed] [Google Scholar]
  57. Hadden J.W. Immunotherapy of human immunodeficiency virus infection. Trends Pharmcol. Sci. 1991;12:107–111. doi: 10.1016/0165-6147(91)90517-v. [DOI] [PubMed] [Google Scholar]
  58. Halstead S.B. Pathogenesis of dengue: Challenges to molecular biology. Science. 1988;29:476–481. doi: 10.1126/science.3277268. [DOI] [PubMed] [Google Scholar]
  59. Hamilton J.R., Overall J.C., Glasgow L.A. Synergistic effect on mortality in mice with murine cytomegalovirus andPseudomonas aerugionsa, Staphylococcus aureus, orCandida albicans infections. Infect. Immunol. 1976;14:928–989. doi: 10.1128/iai.14.4.982-989.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Hardy A.M., Allen J.R., Morgan W.M., Curran J.W. The incidencerate of acquired immune deficiency syndrome in selected populations. JAMA. 1985;253:215–218. [PubMed] [Google Scholar]
  61. Hassett J., Gjerset G.F., Mosley J.W., Fletcher M.A., et al. Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. Blood. 1993;82:1351–1357. [PubMed] [Google Scholar]
  62. Haverkos H.W. Kaposi's sarcoma and nitrite inhalants. In: Bridge T.P., editor. Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS. New York: Raven Press; 1988. pp. 165–172. [Google Scholar]
  63. Hay C.R., McEvoy P., Duggan-Keen M. Inhibitions of lymphocyte IL2-receptor expression by factor VIII concentrate: a possible cause of immune suppression in haemophiliacs. Br. J. Haematol. 1990;75:278–281. doi: 10.1111/j.1365-2141.1990.tb02663.x. [DOI] [PubMed] [Google Scholar]
  64. Hendricks J.C., Medley G.F., Van Griensven G.J., Coutinho R.A., et al. The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS. 1993;7:231–239. doi: 10.1097/00002030-199302000-00012. [DOI] [PubMed] [Google Scholar]
  65. Henrard D.R.Y. Laurian, Mehaffey W.F., Allain J.P. Lack of detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction in the plasma and lymphocytes of seronegative exposed hemophiliacs. Transfusion. 1993;33:405–408. doi: 10.1046/j.1537-2995.1993.33593255601.x. [DOI] [PubMed] [Google Scholar]
  66. Higgins J.A., Goodall A.H. Immune activation in HIV-seronegative hemophiliacs: Is this related to infection with hepattis C virus? Thromb. Haemost. 1991;65:1163. [Google Scholar]
  67. Hilgartner M.W., Buckley J.D., Operskalsi E.A., Pike M.C., Mosely J.W. Purity of factor VIII concentrates and serial CD4 counts. Lancet. 1993;341:1373–1374. doi: 10.1016/0140-6736(93)90943-b. [DOI] [PubMed] [Google Scholar]
  68. Hoff C., Peterson R.D.A. Does exposure to HLA alloantigens trigger immunoregulatory mechanisms operative in both pregnancy and AIDS? Life Sci. 1989;45:iii–ix. doi: 10.1016/0024-3205(89)90055-6. [DOI] [PubMed] [Google Scholar]
  69. Hoff C., James W.C., Hester R.B., Nolan P., Peterson R.D.A. Signs of cellular immunosuppression correlate with HLADR phenotypes in healthy HIV-negative homosexuals: preliminary findings. Human Biology. 1991;63:129–135. [PubMed] [Google Scholar]
  70. Holman R.C., Rodes P.H., Chorba T.L., Evatt B.L. Survival of hemophiliac males with acquired immunodeficiency syndrome with and without risk factors for AIDS other than hemophilia. Am. J. Hematol. 1992;39:275–282. doi: 10.1002/ajh.2830390408. [DOI] [PubMed] [Google Scholar]
  71. Hoover D.R., Saah A.J., Bacellar H., et al. Clinical manifestation of AIDS in the era of pneumocystis prophylaxis. New Engl. J. Med. 1993;329:1922–1926. doi: 10.1056/NEJM199312233292604. [DOI] [PubMed] [Google Scholar]
  72. Horsburgh C.R., Jr., Ou C.Y., Jason J., et al. Concordance of polymerase chain reaction with human immunodeficiency virus antibody detection. J. Infect. Dis. 1990;162:542–545. doi: 10.1093/infdis/162.2.542. [DOI] [PubMed] [Google Scholar]
  73. Huang S.-W., Hong R. Lymphopenia and multiple viral infections. JAMA. 1973;225:1120–1121. [PubMed] [Google Scholar]
  74. Huang S.-W., Lattos D.B., Nelson D.B., Reb K., Hong R. Antibody-associated lymphotoxin in acute infection. J. Clin. Invest. 1973;52:1033–1040. doi: 10.1172/JCI107268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Hughes M.D., Stein D.S., Gundacker H.M., Valentine F.T., Phair J.P., Volberding P.A. Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: Implications for patient monitoring. J. Infect Dis. 1994;169:28–36. doi: 10.1093/infdis/169.1.28. [DOI] [PubMed] [Google Scholar]
  76. Imagawa D., Detels R. HIV-1 in seronegative homosexual men. NEJM. 1991;325:1250–1251. doi: 10.1056/NEJM199110243251713. [DOI] [PubMed] [Google Scholar]
  77. Jaffe H.W., Feorino P.M., Darrow W.W., et al. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Ann. Intern. Med. 1985;102:627. doi: 10.7326/0003-4819-102-5-627. [DOI] [PubMed] [Google Scholar]
  78. Judson F.N. The relationship of HIV infections to infections with pathogenic Neisseria in homosexual men. Med. Clin. North. Am. 1990;74:1353–1366. [Google Scholar]
  79. Kallenius G., Hoffner S.E., Svenson S.B. Does vaccination with bacille Calmette-Guerin protect against AIDS? Rev. Infect. Dis. 1989;11:349–351. doi: 10.1093/clinids/11.2.349. [DOI] [PubMed] [Google Scholar]
  80. Keay S., Tacket C.O., Murphy J.R., Handwerger B.S. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp 160 or HIV-1 or infected with HIV-1. AIDS Res. Human Retroviruses. 1992;8:1091–1098. doi: 10.1089/aid.1992.8.1091. [DOI] [PubMed] [Google Scholar]
  81. Kion T.A., Hoffmann G.W. Anti-HIV and anti-anti-MHC antibodies in alloimmune and autoimmune mice. Science. 1991;253:1138–1140. doi: 10.1126/science.1909456. [DOI] [PubMed] [Google Scholar]
  82. Klenk H.D., Rott R. The molecular biology of influenza virus pathogenicity. Adv. Virus Res. 1988;34:247–281. doi: 10.1016/S0065-3527(08)60520-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Kliks S.C., Nisalak A., Brandt W.E., et al. Antibodydependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 1989;40:444–451. doi: 10.4269/ajtmh.1989.40.444. [DOI] [PubMed] [Google Scholar]
  84. Knüver-Hopf J., Heinze H., Lambrecht B., Mohr H., Beyer J., Schmitt H. Blood donations indeterminate in HIV-1 Western blot analysed by IgM immunoblot and polymerase chain reaction. Vox Sang. 1993;64:89–93. doi: 10.1111/j.1423-0410.1993.tb02524.x. [DOI] [PubMed] [Google Scholar]
  85. Kopec-Schrader E., Tindall B., Learmont J., Wylie B., Kaldor J.M. Development of AIDS in people with transfusionacquired HIV infection. AIDS. 1993;7:1009–1013. doi: 10.1097/00002030-199307000-00016. [DOI] [PubMed] [Google Scholar]
  86. Krasinski K., Borkowsky W., Holzman R.S. Prognosis of human immunodeficiency virus infection in children and adolescents. Pediatr. Infect. Dis. J. 1989;8:216–220. [PubMed] [Google Scholar]
  87. Lafeuillade A., Quilichine R. HIV cofactors in the course of AIDS. Presse Med. 1992;21:1426–1430. [PubMed] [Google Scholar]
  88. Lang Ph., Niaudet P., the Groupe Cooperatif de Transplantation de l'Ile de France Update and outcome of renal transplant patients with human immunodeficiency virus. Transplantation Proc. 1991;23:1352–1353. [PubMed] [Google Scholar]
  89. Laurence J. T-cell subsets in health, infectious disease, and idiopathic CD4+T lymphocytopenia. Ann. Intern. Med. 1993;119:55–62. doi: 10.7326/0003-4819-119-1-199307010-00010. [DOI] [PubMed] [Google Scholar]
  90. Levy J. The transmission of AIDS: the case of the infected cell. JAMA. 1988;259:3037–3038. [PubMed] [Google Scholar]
  91. Littlefield J.W. Possible supplemental mechanisms in the pathogenesis of AIDS. Clin. Immunol. Immunopathol. 1992;65:85–97. doi: 10.1016/0090-1229(92)90211-6. [DOI] [PubMed] [Google Scholar]
  92. Lo S.-H., Tsai S., Bnish J.R., et al. Enhancement of HIV-1 cytocidal effects in CD4+lymphocytes by the AIDS-associated mycoplasma. Science. 1991;251:1074–1076. doi: 10.1126/science.1705362. [DOI] [PubMed] [Google Scholar]
  93. Lorenzo J.I., Molina R., Aznar J.A. Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs. Sangre Barc. 1993;38:5–11. [PubMed] [Google Scholar]
  94. Ludlum C.A., Tucker J., Steel C.M., et al. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative hemophiliacs after transfusions of factor VIII. Lancet. 1985;ii:233–236. doi: 10.1016/s0140-6736(85)90288-0. [DOI] [PubMed] [Google Scholar]
  95. Lui K.-J., Lawrence D.N., Morgan W.M., Peterman T.A., Haverkos H.W., Bregman D.J. A model based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome. Proc. Natl. Acad. Sci. U.S.A. 1986;83:301–305. doi: 10.1073/pnas.83.10.3051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Lusso P., Ensoli R., Markham P.D., et al. Productive dual infection of human CD4+T lymphocytes by HIV-1 and HHV-6. Nature (Lond.) 1989;337:370–373. doi: 10.1038/337370a0. [DOI] [PubMed] [Google Scholar]
  97. Lusso P., Lori F., Gallo R.C. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J. Virol. 1990;64:6341–6344. doi: 10.1128/jvi.64.12.6341-6344.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Macon, W.R., S.-C. Lo, B.J. Poisz, D.C. Monefiori,et al., 1993. Acquired immunodeficiency-syndrome-like illness associated with systemicMycoplasma fermentans infection in a human immunodeficiency virus negative homosexual man. Human Pathol 24: [DOI] [PubMed]
  99. Madhok R., Gracie J.A., Smith J., Lowe G.D., Forbes C.D. Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection. Br. J. Haematol. 1990;76:70–74. doi: 10.1111/j.1365-2141.1990.tb07838.x. [DOI] [PubMed] [Google Scholar]
  100. Madhok R., Smith J., Jenkins A., Lowe G.D.O. T-cell sensitization to factor VIII in haemophilia A? Br. J. Haematol. 1991;79:235–238. doi: 10.1111/j.1365-2141.1991.tb04527.x. [DOI] [PubMed] [Google Scholar]
  101. Mannucci P.M., Gringeri A., De Biasi R., Baudo F., Morfini M., Ciavarella N. Immune status of asymptomatic HIV-infected haemophiliacs: randomized, prospective, two-year comparison of treatment with high-purity or an intermediate-purity factor VIII (FVIII) Thromb. Haemost. 1992;67:310–313. [PubMed] [Google Scholar]
  102. Mares M., Sartori M.T., Girolami A. Prevalence of bleeding as cause of death in HIV-seropositive patients with congenital clotting disorders. Vox Sang. 1992;63:77–78. doi: 10.1111/j.1423-0410.1992.tb01225.x. [DOI] [PubMed] [Google Scholar]
  103. Mathé G. Is the AIDS virus responsible for the disease? Biomed. Pharmacother. 1992;46:1–2. doi: 10.1016/0753-3322(92)90062-c. [DOI] [PubMed] [Google Scholar]
  104. McClean A.R., Nowak M.A. Models of interactions between HIV and other pathogens. J. Theor. Biol. 1992;155:69–86. doi: 10.1016/s0022-5193(05)80549-1. [DOI] [PubMed] [Google Scholar]
  105. McDougal J.S., Hubbard M., Nicholson J.K.A., et al. Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect. J. Clin. Immunol. 1985;5:130. doi: 10.1007/BF00915011. [DOI] [PubMed] [Google Scholar]
  106. Medawar P.B. The art of the soluble. London: Methuen; 1967. [Google Scholar]
  107. Medley G.F., Anderson R.M., Cox D.R., Billard L. Incubation period of AIDS in patients infected via blood transfusion. Nature. 1987;328:719–721. doi: 10.1038/328719a0. [DOI] [PubMed] [Google Scholar]
  108. Mills L.B. Stimulation of T-cellular immunity by cutaneous application of dinitrochlorobenzene. J. Am. Acad. Dermatol. 1986;14:1089–1090. doi: 10.1016/s0190-9622(86)80189-x. [DOI] [PubMed] [Google Scholar]
  109. Minkoff H., Nanda D., Menez R., Fikrig S. Pregnancies resulting in infants with acquired immunodeficiency syndrome or AIDS-related complex: follow-up of mothers, children, and subsequently born siblings. Obstet. Gynecol. 1987;69:288–291. [PubMed] [Google Scholar]
  110. Montagnier L., Bernman D., Guetard D., Blanchard A., et al. Inhibition de l'infectiosite de souches prototype du VIH par des anticorps diriges contre une sequence peptideque de mycoplasme. Comptes rendus Acad. Sci. Paris. 1990;311:425–430. [PubMed] [Google Scholar]
  111. Montaner J.S., Lawson L.M., Gervais A., et al. Aerosol pentamidine for secondary prophylaxis of AIDS-relatedPneumocystis carinii pneumonia. A randomized, placebo-controlled study. Ann. Intern. Med. 1991;114:948–953. doi: 10.7326/0003-4819-114-11-948. [DOI] [PubMed] [Google Scholar]
  112. Moretti M.L. Specific behavioural factors among intravenous drug users have been shown to influence HIV seroconversion. J. InterAm. Med. Health. Assoc. 1992;1:1–8. [Google Scholar]
  113. Morrow W.J.W., Isenberg D.A., Sobol R.E., Stricker R.B., Keiber-Emmons T. AIDS virus infection and autoimmunity: A perspective on the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin. Immunol. Immunopathol. 1991;58:163–180. doi: 10.1016/0090-1229(91)90134-v. [DOI] [PubMed] [Google Scholar]
  114. Msellati P., Dupon M., Morlat P., Lacoste D., et al. A cohort study of 89 HIV-1-infected adult patients contaminated by blood products: Bordeaux 1981–1989. AIDS. 1990;4:1105–1109. doi: 10.1097/00002030-199011000-00008. [DOI] [PubMed] [Google Scholar]
  115. Munoz A., Carey V., Saah A.J., et al. Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J. Acquir. Immune. Defic. Syn. 1988;1:396. [PubMed] [Google Scholar]
  116. National Research Council. AIDS: The Second Decade. Washington, D.C.: National Academy of Sciences; 1990. [Google Scholar]
  117. Naz R.K., Ellauri M., Phillips T.M., Hall J. Antisperm antibodies in human immunodeficiency virus infection: Effects on fertilization and embryonic development. Biol. Reprod. 1990;42:859–868. doi: 10.1095/biolreprod42.5.859. [DOI] [PubMed] [Google Scholar]
  118. Odell T.W., Green J.A. Prolonged zidovudine therapy: confounded byPneumocysitis carinii prophylaxis? JAMA. 1990;263:1635. [PubMed] [Google Scholar]
  119. Oehen S., Hengartner H., Zinkernagel R.M. Vaccination for disease. Science. 1991;251:195–198. doi: 10.1126/science.1824801. [DOI] [PubMed] [Google Scholar]
  120. Ozturk G.E., Kohler P.F., Horsburgh C.R., Kirkpatrick C.H. The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners. J. Clin. Immunol. 1987;7:130–133. doi: 10.1007/BF00916007. [DOI] [PubMed] [Google Scholar]
  121. Padian N.S., Shiboski S.C., Jewell N.P. The effect of number of exposures on the risk of heterosexual HIV transmission. J. Infect. Dis. 1990;161:883–887. doi: 10.1093/infdis/161.5.883. [DOI] [PubMed] [Google Scholar]
  122. Palestine A.G., Polis M.A., de Smet M.D., et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann. Intern. Med. 1991;115:665–671. doi: 10.7326/0003-4819-115-9-665. [DOI] [PubMed] [Google Scholar]
  123. Papadopulos-Eleopulos E. Reappraisal of AIDS. Is the oxidation induced by the risk factors the primary cause? Med. Hypotheses. 1988;25:151–162. doi: 10.1016/0306-9877(88)90053-9. [DOI] [PubMed] [Google Scholar]
  124. Perrin L.H., Zubler R., Hirschel B., Martin J.L., Salomon D., Sauret J.H., Fryc O. Negativation d'une serologie positive pour le virus d'immunodefience humaine (VIH). A propos de deux observations. Schweiz. Med. Wochenschrt. 1988;118/45:1641–1644. [PubMed] [Google Scholar]
  125. Peterman T.A., Stoneburner R.L., Allen J.R., Jaffe H.W., Curran J.W. Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections. JAMA. 1988;259:55–58. [PubMed] [Google Scholar]
  126. Pifer L.W., Wang Y.F., Chiang T.M., Ahokas R., Woods D.R., Joyner R.E. Borderline immunodeficiency in male homosexuals: Is lifestyle contributory? South. Med. J. 1987;80:687–697. doi: 10.1097/00007611-198706000-00006. [DOI] [PubMed] [Google Scholar]
  127. Popper K. Conjectures and refutations. The growth of scientific knowledge. New York: Basic Books; 1962. [Google Scholar]
  128. Porterfield J.S., Kingsley L.A., Berinig M.K., et al. Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J. Clin. Microbiol. 1989;29:1215–1220. doi: 10.1128/jcm.29.6.1215-1220.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Ribot S., Eslami H.H. HIV infection in kidney transplant recipients. N. J. Med. 1992;89:597–599. [PubMed] [Google Scholar]
  130. Rinaldo C.R., Jr., Kingsley L.A., Lyter D.W., et al. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men. J. Infect. Dis. 1986;154:556–561. doi: 10.1093/infdis/154.4.556. [DOI] [PubMed] [Google Scholar]
  131. Rinaldo C.R., Jr., Kingsley L.A., Ho M., Armstrong J.A., Zhou S.Y.J. Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J. Clin. Microbiol. 1992;30:1148–1155. doi: 10.1128/jcm.30.5.1148-1155.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Ritter, M., 1994. AIDS raises death rate for hemophilia. Associated Press release based on CDC press conference, 3 Feb. 1994.
  133. Roithmann S., Tourani J.M., Gastaut J.A., Brice P., et al. Hodgkin's disease associated with HIV infection: clinical characteristics and development. Bull. Cancer. Paris. 1993;79:873–882. [PubMed] [Google Scholar]
  134. Root-Bernstein R.S. Discovering, Inventing and solving problems at the frontiers of knowledge. Cambridge, MA: Harvard University Press; 1989. [Google Scholar]
  135. Root-Bernstein R.S. Do we know the cause(s) of AIDS? Persp. Biol. Med. 1990;33:480–500. doi: 10.1353/pbm.1990.0055. [DOI] [PubMed] [Google Scholar]
  136. Root-Bernstein R.S. Multiple-antigen-mediated autoimmunity (MAMA) in AIDS: a possible model for postinfectious autoimmune complications. Res. Immunol. 1990;141:321–339. doi: 10.1016/0923-2494(90)90024-s. [DOI] [PubMed] [Google Scholar]
  137. Root-Bernstein R.S. Non-HIV immunosuppressive agents in AIDS: a multifactorial, synergistic theory of AIDS aetiology. Res. Immunol. 1990;141:815–838. doi: 10.1016/0923-2494(90)90183-y. [DOI] [PubMed] [Google Scholar]
  138. Root-Bernstein, R.S., 1991. Self, nonself, and the paradoxes of autoimmunity. In: A.I. Tauber, ed. Organism and the Development of Self. Kluwer Academic, pp. 159–209.
  139. Root-Bernstein R.S. HIV and immunosuppressive cofactors in AIDS. EOS. Rev. Immunol. Immunopharm. 1992;12:256–262. [Google Scholar]
  140. Root-Bernstein R.S. AIDS is more than HIV. Genetic Engineering News. 1992;12(no. 13):4–6. [Google Scholar]
  141. Root-Bernstein R.S. Rethinking AIDS. The Tragic Cost of Premature Concensus. New York: Free Press; 1993. [Google Scholar]
  142. Root-Bernstein, R.S., 1994. Preliminary evidence of idiotypeantiidiotype immunie complexes cross-reactive with lymphocyte antigens resulting from pairs of infectious agents associated with AIDS and lupus. Med. Hypoth. In press. [DOI] [PubMed]
  143. Root-Bernstein R.S., Hobbs S.H. Homologies between mycoplasma adhesion pepetide, CD4, and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS. Res. Immunol. 1991;142:519–523. doi: 10.1016/0923-2494(91)90096-2. [DOI] [PubMed] [Google Scholar]
  144. Root-Bernstein R.S., Hobbs S.H. Does HIV ‘piggyback’ on CD4-like surface proteins of sperm, viruses, and bacteria? Implications for co-transmission, cellular tropism and the induction of autoimmunity in AIDS. J. Theor. Biol. 1993;160:249–264. doi: 10.1006/jtbi.1993.1017. [DOI] [PubMed] [Google Scholar]
  145. Root-Bernstein, R.S. & S.H. DeWitt, 1994. CD4 similarity to proteins of infectious agents in AIDS, and autoimmunity. Med. Hypoth. In press. [DOI] [PubMed]
  146. Rosendaal F.C., Smit C., Briet E. Hemophilia treatment in historical perspective: a review of medical and social developments. Ann. Hematol. 1991;62:5–25. doi: 10.1007/BF01714977. [DOI] [PubMed] [Google Scholar]
  147. Roy M.J., Damato J.J., Burke D.S. Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA. 1993;269:2876–2879. [PubMed] [Google Scholar]
  148. Rubenstein A., Sicklich M., Gupta A., Bernstein L., Klein N., et al. Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers. JAMA. 1983;249:2350–2356. [PubMed] [Google Scholar]
  149. Rubin H. Etiology of AIDS. Science. 1988;214:1389–1390. [PubMed] [Google Scholar]
  150. Sabin A. Effectiveness of AIDS vaccines. Science. 1988;251:1161. doi: 10.1126/science.2015033. [DOI] [PubMed] [Google Scholar]
  151. Sabin C., Phillips A., Elford J., Griffiths P., Janossay G., Lee C. Progression of HIV disease in a haemophiliac cohort followed for 12 years. Br. J. Haemoatol. 1993;83:330–335. doi: 10.1111/j.1365-2141.1993.tb08290.x. [DOI] [PubMed] [Google Scholar]
  152. Salk J.P.A. Bretscher, Salk P.L., Clerici M., Shearer G.M. A strategy for prophylactic vaccination against HIV. Science. 1993;260:1270–1272. doi: 10.1126/science.8098553. [DOI] [PubMed] [Google Scholar]
  153. Schinaia N., Ghirardini A., Chiarotti F., Gringeri A., Mannucci P.M., et al. Progression of AIDS among Italian HIV-seropositive haemophiliacs. AIDS. 1991;5/4:385–391. doi: 10.1097/00002030-199104000-00005. [DOI] [PubMed] [Google Scholar]
  154. Schulman S. Effects of factor VIII concentrates on the immune system of hemophiliac patients. Ann. Hematol. 1991;63:145–151. doi: 10.1007/BF01703246. [DOI] [PubMed] [Google Scholar]
  155. Schwarz A., Offerman G., Keller F., Bennhold I., L'age-Stehr J., Krause P.H., Mihatsch M.J. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation data on four cases and review of the literature. Transplantation. 1993;55:95–103. doi: 10.1097/00007890-199301000-00019. [DOI] [PubMed] [Google Scholar]
  156. Shearer G.M., Levy R.B. Noninfectious cofactors in susceptibility to AIDS: possible contributions of semen, HLA alloantigens, and lack of natural resistance. Ann. N. Y. Acad. Sci. 1984;437:49–57. doi: 10.1111/j.1749-6632.1984.tb37121.x. [DOI] [PubMed] [Google Scholar]
  157. Shope E. Swine influenza, III. Filtration experiments and etiology. J. Exp. Med. 1931;54:373–385. doi: 10.1084/jem.54.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Sonnabend J.A. AIDS: An explanation for its occurrence in homosexual men. In: Ma P., Armstrong D., editors. AIDS and Opportunistic Infections of Homosexual Men. Stoneham, MA: Butterworth Publishers; 1989. pp. 450–460. [Google Scholar]
  159. Sonnabend J.A., Saadoun S. The acquired immunodeficiency syndrome: A discussion of etiologic hypothesis. AIDS Res. 1984;1:107–120. doi: 10.1089/aid.1.1983.1.107. [DOI] [PubMed] [Google Scholar]
  160. Sonnabend J.A., Witkin S.S., Portillo D.T. A multifactorial model for the development of AIDS in homosexual men. Ann. N. Y. Acad. Sciences. 1984;437:177–182. doi: 10.1111/j.1749-6632.1984.tb37134.x. [DOI] [PubMed] [Google Scholar]
  161. Sorice F., Ghirardini A., Martino P., Pasqualetti D., et al. Spectrum of HIV infection and AIDS in a cohort of Italian hemophiliacs. Haemotologica. 1989;74:149–154. [PubMed] [Google Scholar]
  162. Stehr-Green J.K., Jason J.M., Evatt B.L., Holman R.C., et al. Geographic variability of hemophilia-associated AIDS in the United States: Effect of population characteristics. Am. J. Hematol. 1989;32:178–183. doi: 10.1002/ajh.2830320304. [DOI] [PubMed] [Google Scholar]
  163. Stott E.J. Anti-cell antibody in macaques. Nature. 1991;353:393–395. doi: 10.1038/353393a0. [DOI] [PubMed] [Google Scholar]
  164. Stricker R.B., McHugh T.M., Moody D.J., Morrow W.J.M., Stites D.P., Shuman M.A., Levy J.A. An AIDS-related cytotoxic antoantibody reacts with a specific antigen on stimulated CD4+cells. Nature. 1987;327:710–713. doi: 10.1038/327710a0. [DOI] [PubMed] [Google Scholar]
  165. Stricker R.B., McHugh T.M., Marx P.A., Morrow W.J.M., Levy J.A., Shuman M.A., Stites D.P., Nyeman P.D. Prevalence of an AIDS-related autoantibody against CD4+T-cells in humans and monkeys. Blood. 1987;70:127A. [Google Scholar]
  166. Stricker R.B., Elswood B.F., Abrams D.I. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS. Immunol. Lett. 1991;29:191–196. doi: 10.1016/0165-2478(91)90169-b. [DOI] [PubMed] [Google Scholar]
  167. Stricker R.B., Elswood B.F., Abrams D.I., et al. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. Immunol. Lett. 1993;36:1–6. doi: 10.1016/0165-2478(93)90060-f. [DOI] [PubMed] [Google Scholar]
  168. Sullivan J.L., Brewster F.E., Brettler D.B., et al. Hemophiliac immunodeficiency: Influence of exposure to factor VIII concentrate, LAV-HTLV-III, and herpes viruses. J. Pediatr. 1986;108:504–510. doi: 10.1016/s0022-3476(86)80823-x. [DOI] [PubMed] [Google Scholar]
  169. Sumaya C.V., Boswell R.N., Ench Y., et al. Enhanced serological and virological findings of Epstein-Barr virus in patients with AIDS and AIDS related complex. J. Infect Dis. 1985;154:864. doi: 10.1093/infdis/154.5.864. [DOI] [PubMed] [Google Scholar]
  170. Süsal C., Kröpelin M., Daniel V., Opelz G. Molecular mimicry between HIV-1 and antigen receptor molecules: a clue to the pathogenesis of AIDS. Vox Sang. 1993;65:10–17. doi: 10.1111/j.1423-0410.1993.tb04518.x. [DOI] [PubMed] [Google Scholar]
  171. Tanenbaum, S.A., R.F. Garry, H. Luo-Zhang, S.S. Alexander & C.A. Leissinger, 1993. Humoral and cellular responses against HIV in multitransfused HIV seronegative hemophiliacs. Absts. 1st National Conf. Human Retroviruses. Abst. #86, p. 71.
  172. Tanenbaum S.A., Leissinger C.A., Garry R.F. Absence of seroconversion of HIV-1 antibody in seroreactive individuals. JAMA. 1993;270:2178. doi: 10.1001/jama.270.18.2178b. [DOI] [PubMed] [Google Scholar]
  173. Taylor J.M., Duo J.M., Detels R. Is the incubation period of AIDS lengthening? J. Acquir. Immune. Defic. Syndr. 1991;4:69–75. [PubMed] [Google Scholar]
  174. Tzakis A.G., Cooper M.H., Dummer J.S., Ragni M., Ward J.W., Starzl T.E. Transplantation in HIV+patients. Transplantation. 1990;49:354–358. doi: 10.1097/00007890-199002000-00025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Urnovitz H.B., Clerici M., Shearer G.M., Gottfried T.D., Robinson D.J., Lutwick L.I., Montagnier L., Landers D.V. HIV-1 antibody serum negativity with urine positivity. Lancet. 1993;342:1458–1459. doi: 10.1016/0140-6736(93)92934-l. [DOI] [PubMed] [Google Scholar]
  176. Vamvakas E., Kaplan H.S. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion. 1993;33:111–118. doi: 10.1046/j.1537-2995.1993.33293158041.x. [DOI] [PubMed] [Google Scholar]
  177. Vandenbroucke J.P., Pardoel V.P.A.M. An autopsy on epidemiologic methods: the case of ‘poppers’ in the early epidemic of the acquired immunodeficiency syndrome (AIDS) Am. J. Epidem. 1989;129:455–457. doi: 10.1093/oxfordjournals.aje.a115156. [DOI] [PubMed] [Google Scholar]
  178. Van Griensven G.J., de Vroom E.M., Goodsmit J., Coutinho R.A. Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Br. Med. J. 1989;298:218–221. doi: 10.1136/bmj.298.6668.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Vega M.A., Guigo R., Smith T.F. Autoimmune response in AIDS. Nature. 1990;345:26. doi: 10.1038/345026a0. [DOI] [PubMed] [Google Scholar]
  180. Vega M.C., See L.C. N-estimation from retrospectively ascertained events with application to AIDS. Biometrics. 1992;48:129–141. [PubMed] [Google Scholar]
  181. Wang R.Y., Shih J.W., Grandinetti T., Pierce P.F., Hayes M.M., Wear D.J., Alter H.J., Lo S.C. High frequency of antibodies toMycoplasma penetrans in HIV-infected patients. Lancet. 1992;340:1312–1316. doi: 10.1016/0140-6736(92)92493-y. [DOI] [PubMed] [Google Scholar]
  182. Ward J.W., Bush T.J., Perkins H.A., et al. The natural history of transfusion-associated infection with human immunodeficiency virus. New Engl. J. Med. 1989;321:947–952. doi: 10.1056/NEJM198910053211406. [DOI] [PubMed] [Google Scholar]
  183. Watson H.G., Ludlum C.A. Immunological abnormalities in haemophiliacs. Blood Rev. 1992;6:26–33. doi: 10.1016/0268-960x(92)90005-b. [DOI] [PubMed] [Google Scholar]
  184. Weber R., Ledergerber W., Opravil M., Siegenthaler W., Lüthy R. Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J. 1990;301:1361–1365. doi: 10.1136/bmj.301.6765.1362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Webster A., Lee C.A., Cook D.G., Grundy J.E., et al. Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet. 1989;ii:63–66. doi: 10.1016/s0140-6736(89)90312-7. [DOI] [PubMed] [Google Scholar]
  186. Weiss R.A. How does HIV cause AIDS? Science. 1993;260:1273–1279. doi: 10.1126/science.8493571. [DOI] [PubMed] [Google Scholar]
  187. Weyer J., Eggers H.J. On the structure of the epidemic spread of AIDS: the influence of an infectious coagent. Int. J. Med. Microbiol. 1990;273:52–67. doi: 10.1016/s0934-8840(11)80239-2. [DOI] [PubMed] [Google Scholar]
  188. Winkelstein W., Jr., Wiley J.A., Padian N.S., Samuel M., Shiboski S., Ascher M.S., Levy J.A. The San Francisco Men's Health Study: Continued decline in HIV seroconversion rates among homosexual/bisexual men. Am. J. Public Health. 1988;78:1472–1474. doi: 10.2105/ajph.78.11.1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Witebsky E., Rose N.R., Terplan K., Pain J.R., Egan R.W. Chronic thyroiditis and autoimmunization. JAMA. 1957;164:1439–1447. doi: 10.1001/jama.1957.02980130015004. [DOI] [PubMed] [Google Scholar]
  190. Zarling J.M., Ledbetter J.A., Sias J., Fultz P., Eichberg J., Gjerset G., Moran P.A. HIV-infected humans but not chimpanzees, have circulating cytotoxic T lymphocytes that lyse uninfected CD4+cells. J. Immunol. 1990;144:2992–2998. [PubMed] [Google Scholar]
  191. Ziegler J.L., Stites D.P. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin. Immunol. Immunopathol. 1986;41:305. doi: 10.1016/0090-1229(86)90001-2. [DOI] [PubMed] [Google Scholar]
  192. Zuck T.F. Silent sequences and the safety of blood transfusions. Ann. Intern. Med. 1988;108:895–896. doi: 10.7326/0003-4819-108-6-895. [DOI] [PubMed] [Google Scholar]

Articles from Genetica are provided here courtesy of Nature Publishing Group

RESOURCES